Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate (2007-5904)

This study has been withdrawn prior to enrollment.

(Halted due to zero accrual and lack of funding)

Sponsor:

Collaborator:

Sanofi

Information provided by (Responsible Party):

Chao Family Comprehensive Cancer Center, University of California, Irvine

ClinicalTrials.gov Identifier:

NCT00598858

First received: January 10, 2008

Last updated: April 3, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	June 2010
Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)